+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia Pacific mHealth Market By Type, By Services, By Devices, By Stakeholders, By Application, By Country, Industry Analysis and Forecast, 2020 - 2026

  • ID: 5026341
  • Report
  • April 2020
  • Region: Asia Pacific
  • 158 Pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

FEATURED COMPANIES

  • Bayer AG
  • Cerner Corporation
  • DexCom, Inc.
  • Johnson and Johnson
  • Koninklijke Philips N.V.
  • Medtronic PLC
The Asia Pacific mHealth Market is expected to witness market growth of 32.7% CAGR during the forecast period (2020-2026).

Emerging mobile health promotion technologies (mHealth) have revolutionized the healthcare industry. In the last few years, the adoption of mHealth has been significant. More than 325,000 mHealth applications are available for apple and android smartphones, according to the recent data. Rising acceptance of mHealth as a primary source of information has positively impelled market growth. Telecom providers and other healthcare IT-focused organizations are now actively involved in telemedicine, which enables remote patient monitoring. In the case of cardiac patients, remote patient tracking is important for the transmission of data on heart rate and rhythm between health care professionals and patients in hospitals or hospitals. The market is projected to grow steadily with growing demand in multi-specialty hospitals.

Neurological monitoring is very important, particularly for patients with neurological diseases such as dementia. Dementia is very common among the elderly. As stated by the United Nations, Asia-Pacific counties such as Japan, China, and Australia have a very high percentage of the population aged 60 years or older and are also projected to increase in the future. It is projected to increase the prevalence of neurological diseases in the region, which will increase the demand for neurological monitoring devices. This will contribute to the development of the market in the region.

China's mHealth market is expected to grow at the high growth during the forecast period. The country's most common disease-specific apps focus primarily on managing hypertension, diabetes, and hepatitis. The use of mHealth devices has seen a major rise in hypertension control. Several health & fitness apps undergo rapid growth among mobile users in Asia. For example, apps such as Keep, Yodo Run, and Qin Baobao are among the Chinese Apple store's most popular health and fitness apps. In addition, Meet you app that monitors the menstruation cycle and, Ping An Good Doctor app provides medical consultation, are likely to witness substantial market penetration over the forecast period.

Based on Type, the market is segmented into Services and Devices. Based on Services, the market is segmented into Monitoring services, Diagnosis services, Healthcare Systems Strengthening Services and Others. Based on Devices, the market is segmented into BP Monitors, Cardiac Monitors, Pulse Oximetry, Blood Glucose Meters, Apnea & Sleep Monitors, Neurological Monitors, Wearable Fitness Sensor Device & Heart Rate Meters and Others. Based on Stakeholders, the market is segmented into Mobile Operators, Device Vendors, Healthcare Providers and Content Players. Based on Application, the market is segmented into Cardiovascular Diseases, Diabetes, Respiratory, Neurology and Other Applications. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Bayer AG, Medtronic PLC, Johnson and Johnson, Koninklijke Philips N.V., DexCom, Inc., Samsung Electronics Co., Ltd. (Samsung Group), Omron Corporation, AllScripts Healthcare Solutions, Inc., Sanofi S.A., Cerner Corporation.

Scope of the Study

Market Segmentation:

By Type
  • Services and
  • Devices

By Services
  • Monitoring services
  • Diagnosis services
  • Healthcare Systems Strengthening Services and
  • Others

By Devices
  • BP Monitors
  • Cardiac Monitors
  • Pulse Oximetry
  • Blood Glucose Meters
  • Apnea & Sleep Monitors
  • Neurological Monitors
  • Wearable Fitness Sensor Device & Heart Rate Meters and
  • Others

By Stakeholders
  • Mobile Operators
  • Device Vendors
  • Healthcare Providers and
Content Players
  • By Application
  • Cardiovascular Diseases
  • Diabetes
  • Respiratory
  • Neurology and
  • Other Applications

By Country
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Companies Profiled:
  • Bayer AG
  • Medtronic PLC
  • Johnson and Johnson
  • Koninklijke Philips N.V.
  • DexCom, Inc.
  • Samsung Electronics Co., Ltd. (Samsung Group)
  • Omron Corporation
  • AllScripts Healthcare Solutions, Inc.
  • Sanofi S.A.
  • Cerner Corporation

Unique Offerings from the Publisher:
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bayer AG
  • Cerner Corporation
  • DexCom, Inc.
  • Johnson and Johnson
  • Koninklijke Philips N.V.
  • Medtronic PLC

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific mHealth Market, by Type
1.4.2 Asia Pacific mHealth Market, by Services
1.4.3 Asia Pacific mHealth Market, by Devices
1.4.4 Asia Pacific mHealth Market, by Stakeholders
1.4.5 Asia Pacific mHealth Market, by Application
1.4.6 Asia Pacific mHealth Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2015, Jun - 2020,Feb) Leading Players
Chapter 4. Asia Pacific mHealth Market by Type
4.1 Asia Pacific Services Market by Country
4.1.1 Asia Pacific mHealth Services Market by Type
4.1.1.1 Asia Pacific Monitoring services Market by Country
4.1.1.2 Asia Pacific Diagnosis services Market by Country
4.1.1.3 Asia Pacific Healthcare Systems Strengthening Services Market by Country
4.1.1.4 Asia Pacific Other Services Market by Country
4.2 Asia Pacific Devices Market by Country
4.2.1 Asia Pacific mHealth Devices Market by Type
4.2.1.1 Asia Pacific BP Monitors Market by Country
4.2.1.2 Asia Pacific Cardiac Monitors Market by Country
4.2.1.3 Asia Pacific Pulse Oximetry Market by Country
4.2.1.4 Asia Pacific Blood Glucose Meters Market by Country
4.2.1.5 Asia Pacific Apnea & Sleep Monitors Market by Country
4.2.1.6 Asia Pacific Neurological Monitors Market by Country
4.2.1.7 Asia Pacific Wearable Fitness Sensor Device & Heart Rate Meters Market by Country
4.2.1.8 Asia Pacific Others Market by Country
Chapter 5. Asia Pacific mHealth Market by Stakeholders
5.1 Asia Pacific Mobile Operators Market by Country
5.2 Asia Pacific Device Vendors Market by Country
5.3 Asia Pacific Healthcare Providers Market by Country
5.4 Asia Pacific Content Players Market by Country
Chapter 6. Asia Pacific mHealth Market by Applications
6.1 Asia Pacific Cardiovascular Diseases Market by Country
6.2 Asia Pacific Diabetes Market by Country
6.3 Asia Pacific Respiratory Market by Country
6.4 Asia Pacific Neurology Market by Country
6.5 Asia Pacific Other Applications Market by Country
Chapter 7. Asia Pacific mHealth Market by Country
7.1 China mHealth Market
7.1.1 China mHealth Market by Type
7.1.1.1 China mHealth Services Market by Type
7.1.1.2 China mHealth Devices Market by Type
7.1.2 China mHealth Market by Stakeholders
7.1.3 China mHealth Market by Applications
7.2 Japan mHealth Market
7.2.1 Japan mHealth Market by Type
7.2.1.1 Japan mHealth Services Market by Type
7.2.1.2 Japan mHealth Devices Market by Type
7.2.2 Japan mHealth Market by Stakeholders
7.2.3 Japan mHealth Market by Applications
7.3 India mHealth Market
7.3.1 India mHealth Market by Type
7.3.1.1 India mHealth Services Market by Type
7.3.1.2 India mHealth Devices Market by Type
7.3.2 India mHealth Market by Stakeholders
7.3.3 India mHealth Market by Applications
7.4 South Korea mHealth Market
7.4.1 South Korea mHealth Market by Type
7.4.1.1 South Korea mHealth Services Market by Type
7.4.1.2 South Korea mHealth Devices Market by Type
7.4.2 South Korea mHealth Market by Stakeholders
7.4.3 South Korea mHealth Market by Applications
7.5 Singapore mHealth Market
7.5.1 Singapore mHealth Market by Type
7.5.1.1 Singapore mHealth Services Market by Type
7.5.1.2 Singapore mHealth Devices Market by Type
7.5.2 Singapore mHealth Market by Stakeholders
7.5.3 Singapore mHealth Market by Applications
7.6 Malaysia mHealth Market
7.6.1 Malaysia mHealth Market by Type
7.6.1.1 Malaysia mHealth Services Market by Type
7.6.1.2 Malaysia mHealth Devices Market by Type
7.6.2 Malaysia mHealth Market by Stakeholders
7.6.3 Malaysia mHealth Market by Applications
7.7 Rest of Asia Pacific mHealth Market
7.7.1 Rest of Asia Pacific mHealth Market by Type
7.7.1.1 Rest of Asia Pacific mHealth Services Market by Type
7.7.1.2 Rest of Asia Pacific mHealth Devices Market by Type
7.7.2 Rest of Asia Pacific mHealth Market by Stakeholders
7.7.3 Rest of Asia Pacific mHealth Market by Applications
Chapter 8. Company Profiles
8.1 Bayer AG
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.6 SWOT Analysis
8.2 Medtronic PLC
8.2.1 Company overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Acquisition and Mergers:
8.2.6 SWOT Analysis
8.3 Johnson and Johnson
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental &Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.3.6 SWOT Analysis
8.4 Koninklijke Philips N.V.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.4.5.2 Product Launches and Product Expansions:
8.4.6 SWOT Analysis
8.5 DexCom, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Acquisition and Mergers:
8.6 Samsung Electronics Co., Ltd. (Samsung Group)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.6 SWOT Analysis
8.7 Omron Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Product Launches and Product Expansions:
8.7.6 SWOT Analysis
8.8 AllScripts Healthcare Solutions, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.5.2 Acquisition and Mergers:
8.9 Sanofi S.A.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.1 Cerner Corporation
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expense
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
Note: Product cover images may vary from those shown
  • Bayer AG
  • Medtronic PLC
  • Johnson and Johnson
  • Koninklijke Philips N.V.
  • DexCom, Inc.
  • Samsung Electronics Co., Ltd. (Samsung Group)
  • Omron Corporation
  • AllScripts Healthcare Solutions, Inc.
  • Sanofi S.A.
  • Cerner Corporation
Note: Product cover images may vary from those shown

Loading
LOADING...